Idaho is getting $625,000 in the settlement of a lawsuit with a prescription drug maker accused of selling products at false or inflated prices.
Attorney General Lawrence Wasden announced the resolution Monday with Mylan Laboratories Inc. and Mylan Pharmaceuticals Inc.
The state sued the companies after conducting its own investigation into the average wholesale price companies post for specific drugs. This price is then used to compute the reimbursent to pharmacies that provide the drugs to Idaho Medicaid clients.
In one case, Wasden says his staff determined a 293 percent difference in the published wholesale price compared to the actual price for a Mylan product.
Since 2005, Wasden’s office has resolved 13 separate cases targeting inflated wholesale prescription drug prices and recovered more than $17.2 million from settling those lawsuits.
Was this article valuable?
Here are more articles you may enjoy.
Cost of Howden-Driven Talent War Rises to $31M for Brown & Brown 
Health Officials Downplay Pandemic Risk From Cruise Hantavirus Outbreak 
Florida Governor Signs Bill Dropping Building Permits for Work Valued at $7,500 or Less 
Florida Woman Drives Elevated Pickup Over Lamborghini Sports Car in Parking Lot 
